Xenadrine Marketer Settles With N.J.; Owner Faces New Suit With FTC
This article was originally published in The Tan Sheet
Executive Summary
FTC announced action against Cytodyne Technologies owner Robert Chinery July 13. The complaint was filed two days after the firm's settlement of false advertising charges exempted Chinery from certain advertising constraints
You may also be interested in...
People In Brief
FDA appoints global, IT heads: The agency has chosen Lou Valdez as associate commissioner for international programs and Lori Davis as chief information officer. Valdez will lead the agency's further international expansion, with office openings planned for India, Latin America and the Middle East, FDA says Jan. 12. Melinda Plaisier stepped down as associate commissioner for international programs in October to become director of the Central region office in FDA's Office of Regulatory Affairs (1"The Tan Sheet" Dec. 8, 2008, p. 8). Davis has been deputy CIO since November 2007 and will now drive FDA's multi-year information technology modernization program, which will improve import and food protection by enhancing system interoperability
People In Brief
FDA appoints global, IT heads: The agency has chosen Lou Valdez as associate commissioner for international programs and Lori Davis as chief information officer. Valdez will lead the agency's further international expansion, with office openings planned for India, Latin America and the Middle East, FDA says Jan. 12. Melinda Plaisier stepped down as associate commissioner for international programs in October to become director of the Central region office in FDA's Office of Regulatory Affairs (1"The Tan Sheet" Dec. 8, 2008, p. 8). Davis has been deputy CIO since November 2007 and will now drive FDA's multi-year information technology modernization program, which will improve import and food protection by enhancing system interoperability
New Jersey Goen Settlement Bars Unsubstantiated Claims
A $750,000 settlement with TrimSpa marketer Goen Technologies closes the second of three lawsuits New Jersey has filed against large supplement firms in the past two years